comparemela.com
  1. Home
  2. Live Updates
  3. Global Sorafenib Market - Breaking News

Latest Breaking News On - Global sorafenib market - Page 1 : comparemela.com

Q BioMed announces publication of pre-clinical research showing superior safety and efficacy against current first line therapy of its drug candidate Uttroside-B for liver cancer

/PRNewswire/ Q BioMed, Inc. (OTCQB: QBIO) a commercial-stage biotechnology development company announces a new publication supporting the potential superior.

United statesSouth koreaRuby john antoDenis corinKeith pinderRajiv gandhi centre for biotechnologyOklahoma medical research foundationPrnewswireq biomed incSecurities exchangeCq biomed incSourceq biomed incAugmented efficacyMurine modelHuman hepatocellularGlobal sorafenib marketChang liver

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.